|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Section 5: Methodology for Quantifying Insulin Release in Man |
Accurate Assessment of ß-Cell Function
The Hyperbolic Correction
From the Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California
Only in the last decade did modeling studies predict, and knockout experiments confirm, that type 2 diabetes is a "2-hit" disease in which insulin resistance is necessarily accompanied by ß-cell defect(s) preventing the compensatory upregulation of insulin secretion. This long- delayed insight was associated with the development of a constant, the "disposition index," describing the ß-cell sensitivity-secretion relationship as a rectangular hyperbola. Shifts in insulin sensitivity are accompanied by compensatory alterations in ß-cell sensitivity to glucose. Insulin-sensitive subjects do not require a massive insulin response to exogenous glucose to maintain a normal blood glucose. But if their insulin sensitivity decreases by 80%, as in late pregnancy, they need a fivefold greater insulin response to achieve an identical disposition index. Women with gestational diabetes have an insulin response similar to that of normal volunteers; at first glance, this suggests similar islet function, but the utility of the disposition index is to normalize this response to the amplitude of third trimester insulin resistance, revealing severe ß-cell deficiency. The index is a quantitative, convenient, and accurate tool in analyzing epidemiologic data and identifying incipient impaired glucose tolerance. Separate major issues remain, however: the causes of insulin resistance, the causes of the failure of adequate ß-cell compensation in type 2 diabetes, and the nature of the signal(s) from insulin-resistant tissues that fail to elicit the appropriate ß-cell increment in sensitivity to glucose and other stimuli. The disposition index is likely to remain the most accurate physiologic measure for testing hypotheses and solutions to these challenges in whole organisms.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  N. M. Lalic, J. Maric, M. Svetel, A. Jotic, E. Stefanova, K. Lalic, N. Dragasevic, T. Milicic, L. Lukic, and V. S. Kostic Glucose Homeostasis in Huntington Disease: Abnormalities in Insulin Sensitivity and Early-Phase Insulin Secretion Arch Neurol, April 1, 2008; 65(4): 476 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes Physiol Genomics, October 19, 2007; 31(2): 264 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Snitker, K. Y. Le, E. Hager, B. Caballero, and M. M. Black Association of Physical Activity and Body Composition With Insulin Sensitivity in a Community Sample of Adolescents Arch Pediatr Adolesc Med, July 1, 2007; 161(7): 677 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rogatsky, B. Balent, G. Goswami, V. Tomuta, H. Jayatillake, G. Cruikshank, L. Vele, and D. T. Stein Sensitive Quantitative Analysis of C-Peptide in Human Plasma by 2-Dimensional Liquid Chromatography-Mass Spectrometry Isotope-Dilution Assay Clin. Chem., May 1, 2006; 52(5): 872 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Spiegel, K. Knutson, R. Leproult, E. Tasali, and E. V. Cauter Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes J Appl Physiol, November 1, 2005; 99(5): 2008 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Gatford, M. J. De Blasio, P. Thavaneswaran, J. S. Robinson, I. C. McMillen, and J. A. Owens Postnatal ontogeny of glucose homeostasis and insulin action in sheep Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E1050 - E1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen and B. L. G. Nyomba Whole body insulin resistance in rat offspring of mothers consuming alcohol during pregnancy or lactation: comparing prenatal and postnatal exposure J Appl Physiol, January 1, 2004; 96(1): 167 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Wagenknecht, C. D. Langefeld, A. L. Scherzinger, J. M. Norris, S. M. Haffner, M. F. Saad, and R. N. Bergman Insulin Sensitivity, Insulin Secretion, and Abdominal Fat: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study Diabetes, October 1, 2003; 52(10): 2490 - 2496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Uusitupa, V. Lindi, A. Louheranta, T. Salopuro, J. Lindstrom, and J. Tuomilehto Long-Term Improvement in Insulin Sensitivity by Changing Lifestyles of People with Impaired Glucose Tolerance: 4-Year Results From the Finnish Diabetes Prevention Study Diabetes, October 1, 2003; 52(10): 2532 - 2538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Thamer, M. Stumvoll, A. Niess, O. Tschritter, M. Haap, R. Becker, F. Shirkavand, O. Bachmann, K. Rett, A. Volk, et al. Reduced Skeletal Muscle Oxygen Uptake and Reduced {beta}-Cell Function: Two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes Diabetes Care, July 1, 2003; 26(7): 2126 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, E. Breda, A. L. Oberg, C. C. Powell, C. Dalla Man, A. Basu, J. L. Vittone, G. G. Klee, P. Arora, M. D. Jensen, et al. Mechanisms of the Age-Associated Deterioration in Glucose Tolerance: Contribution of Alterations in Insulin Secretion, Action, and Clearance Diabetes, July 1, 2003; 52(7): 1738 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stumvoll, P. A. Tataranni, N. Stefan, B. Vozarova, and C. Bogardus Glucose Allostasis Diabetes, April 1, 2003; 52(4): 903 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome: 25-26 August 2002, Washington, DC Diabetes Care, March 1, 2003; 26(3): 933 - 939. [Full Text] [PDF]
|
|
|
|
|
|
R. C. Bonadonna, M. Stumvoll, A. Fritsche, M. Muggeo, H. Haring, E. Bonora, and T. W. van Haeften Altered Homeostatic Adaptation of First- and Second-Phase {beta}-Cell Secretion in the Offspring of Patients With Type 2 Diabetes: Studies With a Minimal Model to Assess {beta}-Cell Function Diabetes, February 1, 2003; 52(2): 470 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Krempler, H. Esterbauer, R. Weitgasser, C. Ebenbichler, J. R. Patsch, K. Miller, M. Xie, V. Linnemayr, H. Oberkofler, and W. Patsch A Functional Polymorphism in the Promoter of UCP2 Enhances Obesity Risk but Reduces Type 2 Diabetes Risk in Obese Middle-Aged Humans Diabetes, November 1, 2002; 51(11): 3331 - 3335. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |